• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

妇科肿瘤学的诊断与治疗进展:妇科癌症筛查

Diagnostic and therapeutic advances in gynecologic oncology: screening for gynecologic cancer.

作者信息

Kim Y B, Ghosh K, Ainbinder S, Berek J S

机构信息

Department of Obstetrics and Gynecology, UCLA School of Medicine 90024, USA.

出版信息

Cancer Treat Res. 1998;95:253-76. doi: 10.1007/978-1-4615-5447-9_9.

DOI:10.1007/978-1-4615-5447-9_9
PMID:9619288
Abstract

Endometrial carcinoma is associated with a good prognosis because patients tend to present with early disease. Mass screening is therefore unlikely to be of benefit. High-risk populations may benefit from screening, but no prospective studies have demonstrated a benefit in any population. The most promising modality for screening appears to be TVS, and a normal TVS may also preclude the need for further evaluation of symptomatic patients. The appropriate use of TVS in patients on tamoxifen is currently unknown. Hysteroscopy and endometrial biopsy may have a role in the evaluation of symptomatic patients but do not appear promising as screening modalities.

摘要

子宫内膜癌预后良好,因为患者往往表现为疾病早期。因此,大规模筛查不太可能有益。高危人群可能从筛查中获益,但尚无前瞻性研究表明对任何人群都有益。最有前景的筛查方式似乎是经阴道超声(TVS),正常的TVS也可能避免对有症状患者进行进一步评估。目前尚不清楚在服用他莫昔芬的患者中TVS的恰当应用。宫腔镜检查和子宫内膜活检可能在有症状患者的评估中发挥作用,但作为筛查方式似乎前景不佳。

相似文献

1
Diagnostic and therapeutic advances in gynecologic oncology: screening for gynecologic cancer.妇科肿瘤学的诊断与治疗进展:妇科癌症筛查
Cancer Treat Res. 1998;95:253-76. doi: 10.1007/978-1-4615-5447-9_9.
2
Screening for gynecologic cancer.妇科癌症筛查
Med Clin North Am. 1999 Nov;83(6):1467-87. doi: 10.1016/s0025-7125(05)70175-9.
3
Screening for gynecologic malignancies: A continuing responsibility.妇科恶性肿瘤筛查:一项持续的责任。
Surg Oncol Clin N Am. 1999 Oct;8(4):703-23, vii.
4
Screening for gynecologic and colorectal cancer: is it adequate?妇科和结直肠癌筛查:是否足够?
Womens Health Issues. 1992 Summer;2(2):83-92; discussion 92-3. doi: 10.1016/s1049-3867(05)80276-2.
5
Gynecologic malignancies.妇科恶性肿瘤
Surg Clin North Am. 2008 Apr;88(2):301-17, vi. doi: 10.1016/j.suc.2008.01.004.
6
PET/CT in gynecologic cancer: present applications and future prospects--a clinician's perspective.妇科癌症的 PET/CT:现状与未来展望——临床医师视角
Obstet Gynecol Clin North Am. 2011 Mar;38(1):1-21, vii. doi: 10.1016/j.ogc.2011.02.001.
7
Gynecologic cancers.妇科癌症
Prim Care. 2009 Mar;36(1):115-30, ix. doi: 10.1016/j.pop.2008.10.001.
8
International Gynecologic Cancer Society (IGCS) 2016: Meeting report.国际妇科癌症协会(IGCS)2016年会议报告
Gynecol Oncol. 2017 Jan;144(1):11-15. doi: 10.1016/j.ygyno.2016.11.016. Epub 2016 Nov 12.
9
Staging of gynecologic malignancies.妇科恶性肿瘤的分期
Top Magn Reson Imaging. 2001 Apr;12(2):105-29. doi: 10.1097/00002142-200104000-00004.
10
Multidisciplinary International Conference on Gynecologic Cancer, Bologna, Italy, June 8-12, 2005.
J Cell Physiol. 2006 Jul;208(1):1-5. doi: 10.1002/jcp.20640.

引用本文的文献

1
Endometrial cancer epidemiology and prevention in Federation of Bosnia and Herzegovina, B&H.
Bosn J Basic Med Sci. 2004 Oct;4(4):63-5. doi: 10.17305/bjbms.2004.3364.